{"Title": "Quantitative Clinical Pharmacology Input to SARS-CoV-2 Therapeutics Should Be Based on Robust Data", "Year": 2020, "Source": "Clin. Pharmacol. Ther.", "Volume": "108", "Issue": 2, "Art.No": null, "PageStart": 187, "PageEnd": null, "CitedBy": 2, "DOI": "10.1002/cpt.1872", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85084467544&origin=inward", "Abstract": null, "AuthorKeywords": null, "IndexKeywords": ["Betacoronavirus", "Coronavirus Infections", "Drug Repositioning", "Humans", "Hydroxychloroquine", "Pandemics", "Pharmacology, Clinical", "Pneumonia, Viral", "SARS Virus"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 1, "EID": "2-s2.0-85084467544", "SubjectAreas": [["Pharmacology", "PHAR", "3004"], ["Pharmacology (medical)", "MEDI", "2736"]], "AuthorData": {"8702431000": {"Name": "Standing J.F.", "AuthorID": "8702431000", "AffiliationID": "60022148", "AffiliationName": "Great Ormond Street Institute for Child Health, University College London"}}}